Skip to main content
Caplight Logo









Delox

Delox

Private
CascaisHealthcare & Life Scienceshttps://delox-global.com/

Last Round

Series A

Jan 1, 2026

Total Funding Raised

$4.89M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Delox is a healthtech company that develops advanced bio-decontamination systems utilizing a proprietary solid hydrogen peroxide formulation to eliminate microorganisms in controlled environments.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

bio-decontaminationhydrogen peroxide decontaminationVPHPvaporized hydrogen peroxidesterilization equipmentbiosafety cabinet decontaminationcleanroom decontaminationbiotech equipmentlaboratory safetycontamination controldeconsolid-state hydrogen peroxidebiodeconmedical devicepreventive maintenance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delox Comparables

Compare Delox with similar companies based on industry and business-model similarity.

Delox comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Solidfog Technologies
81%
Ecolab
74%
JCE Biotechnology
73%

Delox Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 1, 2026
GrantNov 1, 2023
VC RoundNov 1, 2023
SeedMay 18, 2022
GrantMay 3, 2021

Key People

Founding team and executive leadership

Fernando Antunes

CTO and Co-Founder

Founding Team

Fadhil Musa

CEO, Co-Promotor

Executive Team

Delox Investors

Notable investors and investment history

Delox investors
InvestorRounds
European Innovation Council FundSeries A, Grant
Caixa CapitalSeed, Series A, Pre Seed
Kiilto VenturesSeed
Bionova CapitalSeed, Pre Seed
Beta CapitalSeries A
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 63% MoM.

  • Feb 19, 2026

    Grew 100% QoQ, from 6 to 12 employees.

Delox Filings

Explore SEC and related filing metadata, where available.

Delox filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Delox's valuation, stock price, and market status.

Is Delox a public or private company?

Delox is a private company.

What is the current stock price of Delox?

Delox is a private company with no public stock price. No recent secondary market data is available.

How much is Delox worth (valuation)?

Valuation information for Delox is not publicly available.

Can I buy Delox stock?

Delox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Delox's last funding round?

Delox's most recent funding round was Series A on January 1, 2026.

Who are the main investors in Delox?

Key investors in Delox include Kiilto Ventures, Beta Capital.

Will Delox IPO soon?

No public IPO plans have been announced for Delox.

How can I track Delox secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delox's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCascais
Employee Range10
Year Founded2018
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?